Patent 7872045 was granted and assigned to Allergan, Inc. on January, 2011 by the United States Patent and Trademark Office.
A method is disclosed herein comprising administering a compound and a second drug to an eye of a mammal for the treatment of glaucoma or the reduction of intraocular pressure, said compound represented by the general formula I;